13.02 0.00 (0.00%)
After hours: 4:00PM EDT
|Bid||13.01 x 1800|
|Ask||13.02 x 800|
|Day's Range||12.98 - 13.45|
|52 Week Range||8.92 - 18.00|
|Beta (3Y Monthly)||0.10|
|PE Ratio (TTM)||317.56|
|Earnings Date||May 11, 2017 - May 12, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.33|
OptimizeRx Corp. (OPRX), a leading provider of digital health solutions for payers, medtech companies, medical associations and the pharmaceutical industry, has secured a three-year exclusive partnership with NewCrop, a provider of integrated electronic prescribing software, to deliver real-time digital health messages to NewCrop’s e-prescribing network of more than 65,000 healthcare professionals. The agreement builds upon a long standing, profitable relationship between the two partners, and solidifies OptimizeRx as the largest digital platform connecting life sciences to the point-of-care.
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will host two plenary sessions at the 13th Annual Digital Pharma East conference being held at the Pennsylvania Convention Center in Philadelphia on September 17-20, 2019. Bringing together more than 1,000 participants, this conference will feature latest case studies and senior-level discussions with pharma companies, health systems, physicians, health-tech companies, startups and non-traditional healthcare companies involved in digital health. The first plenary session, “Success in Today’s Evolving Pharma Marketing Landscape,” will be hosted by Steve Silvestro, chief commercial officer of OptimizeRx, at 11:00 a.m. Eastern time on September 17.
Zacks.com featured highlights include: Digital Turbine, Perion, Controladora Vuela, OptimizeRx and Eldorado Gold
OptimizeRx Corp. (OPRX) to acquire RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity. The RMDY Health platform is used by pharma, payers, MedTech companies and medical associations nationwide.
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in the Lake Street Capital Markets 3rd Annual Best Ideas Growth (BIG3) Conference being held on September 12, 2019 at the Parker New York. The company’s digital health network is expanding into the acute care market after reaching more than half of the ambulatory patient market in the U.S. The event is for institutional clients of Lake Street and is by invitation only.
Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won't get...
ROCHESTER, Mich., Aug. 07, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.
OptimizeRx's (OPRX) second-quarter 2019 results are likely to benefit from increased sales of core financial and brand messaging products.
OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ROCHESTER, Mich., July 24, 2019 -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, will hold a conference call.
ROCHESTER, Mich., July 23, 2019 -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, announced a new partnership.
The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Institutions often own...
The Russell 2000 Index is a small-cap stock market index that includes the bottom 2,000 companies found in the Russell 3000 index. The Russell Microcap Index includes the 1,000 smallest securities found ...
OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell Microcap® and 3000® Indexes at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the U.S. market opens on July 1, according to a preliminary list of additions posted June 21. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “We are honored to be included in the Russell Indexes,” said OptimizeRx CEO, William Febbo.
The Zacks Analyst Blog Highlights: Malibu Boats, MEDIFAST, OptimizeRx, Synergy Resources and Pioneer Natural